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Abstract 
Purpose:We aimed to achieve detailed biomaterials characterization of a drug delivery 
system for local cancer treatment based on electrospun titanocene trichloride-loaded 
resorbable polycaprolactone (PCL) fibers. Methods: The PCL fibers, were characterized 
for their structural, morphological and physical properties. The drug release kinetics of the 
titanocene complex was investigated at different concentrations, to obtain a set of 
correlations between structure and tuneable release. After  exposing cancer cells directly 
onto the surface of PCL fibers, the anti-proliferative effects of titanocene-loaded PCL 
were evaluated by: (i) counting viable cells via live/dead staining methods, and (ii) 
analyzing cell apoptosis. Results and Conclusion: Titanocene concentration influenced 
fiber diameters that were reduced for PCL filled with the titanocene. X-rays analysis 
suggested that the titanocene, encapsulated into the PCL fibers, is not allowed to 
crystallize and exists as amorphous aggregates into the fibers. The titanocene release 
curves presented two stages not related to PCL degradation: an initial burst release 
followed by a release linear with time, extending for very long time. All of the titanocene-
loaded fibers showed sustained drug release properties suggesting their potential clinical 
applicability for the treatment of local cancer diseases.  
Running title: Antitumor activity of  titanocene loaded PCL electrospun fibers. 
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 Introduction 
In the last decades the successes reached by drug delivery systems based on nano-structerd 
biomaterials have been particularly relevant for cancer treatments.  
In particular, the use of electrospun micro- and nano-fibres as antitumor drug carriers has 
attracted a great deal of attention as targeting delivery system of the antitumor drugs in 
postoperative local chemotherapy (1-15). Recent researches have shown that the fibers 
have many advantages, such as reduced toxicity and optimal drug release profile (16-28). 
Xie et al. encapsulated paclitaxel into PLGA and report that electrospun microfibers and 
nanofibers are efficient for sustained delivery of paclitaxel to treat C6 Glioma in vitro. 
They showed that the efficacy of the encapsulated molecule was comparable to the 
commercial paclitaxel formulation (29). Jing et al. developed implantable poly (ethylene 
glycol)-poly (L-lactic acid) diblock copolymer fibers for the controlled release of 1,3-bis 
(2-chloroethyl)-1-nitrosourea (30).  
Recently, electrospun fibers as well as silica and non-silica-based materials have been 
used to incorporate organo-metallic compounds, such as titanocene dichloride, in order to 
improve both their safety and efficacy. Indeed, the titanocene complexes show low 
solubility and short half life in the human body, characteristics that have negatively 
affected their efficacy in phase II clinical trials in patients with metastatic breast cancer 
and metastatic renal cell carcinoma. Although titanocene dichloride, incorporated into 
PLLA fibers by electrospinning method, was released in an active form from the system, it 
is also evident that titanocene dichloride release mainly depended on PLLA degradation 
rather than simple diffusion from the fibers (31). Central to the further development of 
these titanocene-loaded PLLA fibers for application in local anti-cancer treatment is the 
prospective ability to control their degradation rate and the delivery of titanocene 
complexes. A problem not easy to solve since the inflammatory response associated with 
PLLA fibers implantation induces the production of “reactive oxygen species” (ROS) and 
enzymes, such as serine proteases and lipases, that might dramatically increase the PLLA 
degradation rate (32, 33)  
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Several studies have demonstrated that the transport of titanocene complexes into the cell, 
their binding to DNA and to biologically important molecules, and their citotoxicity may 
change on the basis of the titanocene derivative used.  
These results moved our interest to the study of the dependence both of the titanocene 
complex type and of the biomaterial used for fiber synthesis on the final anticancer 
activity.  
Poly(ε-caprolactone) (PCL) is selected as the candidate synthetic polymer because it is 
electrospinnable (34), biocompatible, biodegradable, economical and widely used for 
various biomedical applications including drug delivery system. PCL is a semicrystalline 
polymer with a melting point of about 60°C and a glass transition temperature of -60°C, 
which gives the polymer a rubbery behavior at room temperature and, as a consequence, 
good permeability to low molecular weight drugs in delivery systems. The homopolymer 
has a degradation time of the order of two years due to its hydrophobic and semicrystalline 
nature (35).  
In addition, PCL nanofibers prepared by simply electrospinning blends of drug and 
polymer carriers for drug releases for pharmaceutical applications has been reported. 
However, the major disadvantage of this blend-electrospinning procedure is the severe 
burst release phenomenon (36). Burst releases lead to higher initial drug delivery, 
reducing the effective lifetime of the device (37). Many investigations using nanofibers for 
release applications have demonstrated the weakness of blend-electrospinning method and 
highlighted the significant role of drug-carrier interaction in controlled releases (38).  
Between the titanocene complexes, our previous researches have demonstrated that 
titanocene trichloride showed the best performance in terms of hydrolytic stability .  
In addition, titanocene trichloride, which has only one cyclopentadienyl ring coordinated, 
so less steric encumbrance, with more electronic unsaturation, and having three leaving 
groups, showed the best dispersion into the PCL fibers. 
Finally, titanocene trichloride has shown a significant cytotoxic activity, similar to the 
cisplatin’s on human embryonic kidney cells (1).  
In this paper we report a study of the parameters for incorporation of a titanocene three 
chloride complex, shown below: 
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in biocompatible polymeric Polycaprolactone (PCL) nano-fibrous mats, obtained by 
electrospinning technology. The non woven membranes, obtained by optimizing the 
process parameters, were characterized for their structural, morphological and physical 
properties. The drug release kinetics of the titanocene complex was investigated at 
different concentrations, to obtain a set of correlations between structure and tuneable 
release. The anti-proliferative effects of complex and titanocene complex-loaded PCL was 
evaluated on glioblastoma cell line. 
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 Materials and Methods  
Materials 
All manipulations were carried out under oxygen- and moisture-free atmosphere in a 
MBraun MB 200 glove-box. All the solvents for the synthesis were thoroughly 
deoxygenated and dehydrated under argon by refluxing over suitable drying agents, while 
NMR deuterated solvents (Euriso-Top products) were kept in the dark over molecular 
sieves. The anhydrous compound TiCl4, (Strem, Aldrich) was used as received. Potassium 
hydride and lithium buthyl, PCL (Mn 80 000), acetone and phosphate buffer were 
purchased from Sigma-Aldrich. A mechanical mixture of the PCL and PCL + 5% [C5H4-
CH2CH2OCH3]TiCl3 powders was obtained by moulding both components in a hot press 
(Carver Inc.) at 90 °C, forming a 50 ±  5 µm thick film, which was rapidly quenched in a 
bath at 25°C. Glioblastoma human cancer cell line (A-172) used in the present 
investigation was obtained from ATCC (American Type Culture Collection), grown in 
Dulbecco’s Eagle medium, supplemented with 10% fetal bovine serum, penicillin 
(100U/mL) and streptomycin (100mg/ml) (all purchased from Hyclone), at 37°C in a 5% 
CO2 and 95% air atmosphere. 
Synthesis of [C5H4-CH2CH2OCH3]TiCl3 
The half-titanocene [C5H4-CH2CH2OCH3]TiCl3, was synthesized following the procedure 
previously reported in the literature (13, 39). 
To a solution of neutral ligand [C5H5-CH2CH2OCH3], prepared following  the procedure 
reported in the ref. (45) (1.0 g, 8.1 mmol) in THF dry (40 ml), a stoichiometric amount of 
nBuLi (2.5 M solution in hexane, 3.5 ml) was slowly added at -78°C. The solution was 
warmed up to room temperature and left stirred overnight, obtaining a yellow lithium 
intermediate. Afterward the solution was treated at -78°C with 0.85 ml (8.1 mmol) of 
TiCl4 and stirred overnight and then it was filtered to remove LiCl. The solvent was 
evaporated at reduced pressure and the red-brown solid dried in vacuum. The yield was 
quantitative. Elemental analysis (C, H, N) agreed with the proposed formulation and 1H 
and 13C NMR experiments were used for the full characterization of the complex. 
Electrospinning Procedure 
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Electrospinning of PCL fiber was carried out at room temperature at a high voltage of 20-
30 kV (HV Power Supply, Gamma High Voltage Research, Ormond, FL). The spinneret 
used in the experiments had an inner diameter of 0.8 mm. A copper wire was mounted in 
the spinneret and used as the positive electrode. Grounded aluminium foil was used as the 
counter electrode and mounted at a distance of 20, 25 and 30 cm from the spinneret.  
Voltage, distance of the counter electrode, flow rate, polymer concentration were 
optimized to produce PCL nano-fibrous mats composed of individual fibrils without bead 
formation. PCL with 1%, 3% and 5% (wt/wt) of the Titanocene complex, respect to the 
polymer, were stirred vigorously for 1 h in acetone until complete dissolution of both 
components, and then spun utilizing the same conditions of pristine PCL. 
 
Material characterization 
X-ray Diffraction (XRD) Measurements. XRD measurements were carried out on the spun 
samples with a Brucker diffractometer (equipped with a continuous scan attachment and a 
proportional counter with Ni-filtered Cu KR radiation (λ) 1.54050 Å). 
Scanning Electron Microscopy (SEM). The morphology and diameter of the electrospun 
nanofibers were determined with a scanning electron microscope (SEM; JEOL JSM-
T300). A small section of the fiber mat was placed on the SEM sample holder and sputter-
coated with gold prior to the analysis. 
The fiber diameter distribution was determined by Sigma SacnPro 5. About 200 fibers 
were considered, comparing their dimensions respect to the reference bar of SEM image. 
Samples were taken from many places of the membranes to control the homogeneity of 
the fibers distribution. 
Energy Dispersive X-ray Spectroscopy (EDX). Some samples were also characterized by 
microanalysis to investigate their chemical structure. Elemental analysis and element 
mapping were conducted with a field-emission scanning electron microscope (FESEM, 
model LEO 1525, Carl Zeiss SMT AG, Germany) equipped with an EDX spectroscope 
(INCA Energy 350, Oxford Instruments, Witney, UK). 
Elemental analysis. The elemental analyses for C, H, N, Cl were recorded on a 
ThermoFinnigan Flash EA 1112 series and were performed according to standard 
microanalytical procedures. 
NMR analysis. 10 mg of complex was dissolved in CDCl3 and 1H and 13C {1H} NMR 
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spectra were recorded at 298 K on a Bruker Avance 300 spectrometer operating at 300 
MHz (1H) and 75 MHz (13C) and referred to internal tetramethylsilane. 
Release kinetics. The in vitro release kinetics of the Titanocene molecules in a fixed 
volume of a physiological saline solution or in phosphate buffer solution were obtained by 
ultraviolet spectrometric measurement at ambient temperature, using a Spectrometer UV-
2401 PC SHIMADZU. 
Solutions were prepared at a known concentration of titanocene and a linearity between 
the absorbance and concentration was found. The tests were performed using rectangular 
specimen of 8 cm2, with thickness of 30-60 micron and weight of 20 mg, placed into 25 
mL of physiological saline solution (0.9 %) at room temperature and 100 rpm in an orbital 
shaker (VDRL MOD. 711+, Asal S.r.l.). After specific intervals, the solution was removed 
and the absorbance measured, and the same volume was replaced with fresh one. The 
concentration value at specified time intervals was derived from the linear dependence of 
concentration on absorbance. 
Determination of cell viability and apoptosis.  
In vitro antitumor activities of titanocenes loaded-PCL fiber mats were analyzed by 
Apotox-GloTriplex Assay (Promega, Milan, Italy). Exponentially growing A-172 cells 
were seeded in quadruplicate into 96-well flat-bottomed plates in 200 µl of complete 
medium at a concentration of 5×103 cells/well and allowed to attach overnight. . After 24 
h, complex and PCL+complex (5%) fiber mat were added to cell cultures and culturing for 
96 h. Then, 20 μl of Viability/Cytotoxicity reagent containing both GF-AFC substrate and 
bis-AAF-R110 substrate was added to all wells, and briefly mixed. After incubation for 30 
min at 37°C, fluorescence (400Ex/505Em) was measured by a Fluorescence Multi-well 
Plate Reader. For analysis of apoptosis, 100 μl of Caspase-Glo 3/7 reagent was added to 
all wells and incubated for 1 h at room temperature. Luminescence was measured and 
recorded. Control wells (100% viability), in which the test compound was absent, were 
included in all experiments. All data points represent an average of at least four assays. 
Measurement of cell density  
The cell density was evaluated at different time points by phase-contrast microscopy after 
being exposed to control PCL or PCL+complex (5%) fiber mats. A-172 cells (5×104) were 
seeded into 24-well culture plate, incubated with PCL or PCL+complex (5%) up 96 h, 
then stained with trypan blue and photographed post-plating under a phase-contrast 
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microscope with the use of an Olympus camera and Kodak T-Max 400 film, at the same 
magnification for all cultures. Five random fields were selected containing minimally 200 
cells/field. Data from three to seven assays were analyzed for statistical significance by 
analysis of variance (ANOVA), and are shown graphically as mean ± SEM (p values 
<0.05 were defined as significant). 
 
Results and discussion 
Morphology and structure of the pure and filled samples 
Many internal as well as external parameters can influence the electrospinning process 
and, as a consequence, the fiber morphology. Indeed it is difficult to isolate the effect of 
each parameter since they all are interrelated. For this reason, typically a trial-and-error 
approach has been employed by varying the solution properties and spinning parameters 
until uniform defect-free fibers are obtained. 
According to the results of a previous paper (40), we chose acetone, as solvent for PCL 
and PCL loaded with different concentrations of titanocene, also considering that 
titanocene is soluble in this solvent. Dissolving PCL in acetone, we tried different polymer 
concentrations, with a distance of the needle from the screen of 20 cm, 25 cm or 30 cm, 
alternatively. The concentration of the PCL solutions influences the spinning of fibers and 
also controls the morphology. As reported in literature (13-23), also in our case the 
formation of beads along the fibers took place at low PCL concentrations, and at high flux 
(mL/h). 
As the concentration of PCL was increased and the flux decreased, continuous nanofibers 
without bead formation were obtained by electrospinning from 15 and 17.5 wt % 
solutions. 
Analyzing the experimental results, we chose a concentration of 17.5 %, with a distance of 
30 cm, to spin either the pure PCL or the samples filled with titanocene, and in Figure 1 
we show the SEM of the obtained fibers of PCL (a), and PCL charged with titanocene at 
1% (b), 3% (c), and 5% (d). The fibers diameter distribution is shown for each sample, 
too. 
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Fig. 1 
(a) 
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(d) 
  
 
 
The nano-fibrous structure of pristine PCL sample is evident, composed of individual, 
uniform, and randomly oriented fibers with an average diameter at 1.5 µm. 
The addition of the titanocene complex at different concentrations of 1%, 3%, and 5% 
caused no noticeable change in the morphology. However it resulted in electrospun 
nanofibers with significantly lower average diameter, in comparison with pure PCL. The 
fiber diameters are centred at 0.75 µm (1%), 1.0 µm (3%) and 0.85 µm (5%) for the three 
concentrations, respectively. Thus, it is most probable that the dispersion of titanocene 
complex structures improved the electrospinnability of the mixture, as denoted from the 
lower average diameter of nanofibers obtained. Since increase in conductivity and charge 
density generally is reported in literature as responsible of the smaller fibre diameters, we 
can hypothesize this effect by adding the titanocene complex into the PCL solution in 
acetone. Some rare beads appear, possibly due to clusters of the titanocene complex 
molecules on the surface of the microfibers. 
To determine the structural organization of the titanocene complex in the PCL fibers, we 
determined the chemical structure on the surface of the composite fibers with FESEM-
EDX. Figure 2 shows the EDX analysis of electrospun fibers PCL + 5% Titanocene on the 
surface (a) and after thermal degradation at 450°C (b). 
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Fig. 2 
 
On the surface (2a) besides the elements always appearing in the micrographs (such as Fe 
and Cr due to the iron support of the samples and Al, on which the membrane was 
electrospun) we observe that the peaks of Titanium are very small, almost in the noise. 
However, if we submit the sample to a thermal oxidation up to 450°C, followed by an 
EDX analysis (2b) we observe the peaks of Titanium much higher respect to the very 
small ones on the surface. This is an indication that the titanocene complex is located 
inside the fibers, probably with a very small fraction on the surface. 
A confirm of the titanocene presence into the electrospun membranes was obtained by 
analysing a part of the membrane treated with the complex via 1H NMR in acetone-d6, and 
shown in Figure 3, in which 1H-NMR spectra of: PCL (3a), [C5H4-CH2CH2OCH3]TiCl3 
(3b)  and PCL+ 5% [C5H4-CH2CH2OCH3] TiCl3 (3c) are reported. 
We observe the presence of the peaks ascribable to the complex well developed and 
evident. However some of the peaks of the complex changed significantly their chemical 
shift. In fact, for example, by examining the zone relative to the hydrogens of 
cyclopentadienyl we noticed some signals shifted to lower fields (see Fig. 3). This fact can 
be tentatively attributed to a strong interaction between the complex, in neutral or cationic 
form, and the membrane. The cationization could occur because of strong electric field 
used for electrospinning. 
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 Fig. 3 
 
Figure 4 shows the XRD diffractograms of pure [C5H4-CH2CH2OCH3]TiCl3 (a); PCL+ 
5% [C5H4-CH2CH2OCH3]TiCl3 mechanical mixture (b), electrospun PCL charged with 
titanocene at 1% (c), 3% (d), and 5% (e). 
 
Fig. 4  
 
(a) 
(c) 
(b) 
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The [C5H4-CH2CH2OCH3]TiCl3 complex powders (4a) are very crystalline, showing the 
most intense peaks at 8° and 17° of 2ϑ. The PCL, spun from the 17.5 % solution in 
acetone, with 1% (4c), 3% (4d) and 5% (4e) shows the PCL crystalline structure well 
developed with the main peaks appearing at 21.4° of 2ϑ and 23.8° of 2ϑ and a reduced 
amorphous fraction. Interestingly, observing the diffractograms of the filled electrospun 
membranes, we can notice that even in the most concentrated sample, that is the 5% 
[C5H4-CH2CH2OCH3]TiCl3, the crystalline peaks of the titanocene complex do not appear 
at all (4e). We suggest that the complex, encapsulated into the PCL fibers, is not allowed 
to crystallize and exists as amorphous molecular aggregates or solid solution into the 
fibers. This result was already reported for a titanocene-dichloride in polylactic acid 
(PLLA) electrospun from dichloromethane (25). To ascertain that the absence of 
crystalline peaks of [C5H4-CH2CH2OCH3]TiCl3 is not due to its low concentration, we 
prepared a mechanical mixture of the complex and PCL, at the same concentration (5% 
complex) as the electrospun membrane, and the diffractogram is shown in Figure 4 (b). 
We observe that both the most intense peaks of the titanocene complex are very well 
evident into the diffractogram, confirming that in the membranes, where the peaks do not 
appear, the complex is in the amorphous state. 
 
In vitro Release Properties 
Because of the particular characteristics of the tumor microenvironment and tumor 
angiogenesis, it is necessary to design drug delivery systems that specifically target anti-
cancer drugs to tumors. Most of the conventional chemotherapeutic agents have poor 
pharmacokinetics profiles and are non-specifically distributed in the body leading to 
systemic toxicity associated with serious side effects. Therefore, the development of drug 
delivery systems able to target the tumor site is becoming a real challenge that is currently 
addressed. To this aim it is of utmost importance to tailor the release profiles in different 
environments, depending on the many parameters that it is possible to modulate for the 
specific applications. For a local controlled release of elecrospun membranes it is possible 
to modulate: a) drug concentration; b) drug location (inside and/or outside the fibers); c) 
diameter of the fibers, which in turn determines the membrane porosity; d) biodegradation 
time of the polymeric matrix, that can be quicker than drug diffusion or can 
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simultaneously occur, contributing to the delivery. In the present case we chose a polymer, 
PCL, whose biodegradation is very slow, and therefore we can modulate other parameters 
without its influence. We investigated the effect of varying the concentration of the 
titanocene complex, whose location is mainly inside the PCL fibers and studied the release 
kinetics in physiological and phosphate buffer solution. In forthcoming papers we will 
investigate the other parameters (fiber diameter and polymeric matrix biodegradation 
time) with the aim to reach a complete correlation picture for the release of the titanocene 
complex from electrospun polymeric membranes. 
In Figure 5 the absolute and pecentage release of titanocene at different concentrations, 
monitored up to 29 days, is shown. As explained in the experimental part, we took 
rectangular specimen of 8 cm2 of same weight (20 mg), and therefore the maximum 
quantity of complex to be released is 0.2 mg (for 1% membrane); 0.6 mg (for 3% 
membrane); and 1 mg (for 5% membrane).  
Since in the first stage the fraction of complex released for the membrane with 1% of it is 
about 50%, this membrane reaches the 100% release in a shorter time respect to the others, 
that is after 400 hours. The 3% and 5% membranes, at this time have released 38% and 
21%, respectively. If the quantity of complex released in the burst is mainly dependent on 
the geometric factors, it is evident that it influences the less concentrated samples, and its 
influence decreases on increasing the complex concentration. 
Fig. 5 
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The three curves present mainly two stages: a first stage, quick as a “burst“ followed by a 
successive stage, in which the release of the complex is linear with time. It is worth noting 
that the absolute quantity (in mg) released in the first stage is almost the same for the three 
samples, and therefore it results independent of the initial concentration. This noticeable 
result is confirmed if we report the quantity of the complex delivered in the second stage 
(at 500 hours), as a function of the initial concentration, as shown in Figure 6: 
 
Fig. 6 
 
The points follow a straight line that extrapolates at zero loading to the same value (0.18 
mg) observed in Figure 6, as first exit of the complex. The initial burst, found in many 
systems, has been generally associated to the drug on the surface of fibers, that is directly 
delivered, without being slowed down by the diffusion phenomena. The present result 
could indicate that the fraction of drug deposited on the surface, during the electrospinning 
process, mainly depends on geometrical factors and less on the drug concentration. This 
result would be very interesting, if confirmed, and needs further investigations to be 
accepted as a general behavior. 
In figure 7 the release in phosphate buffer solution as % released up to 96 hours is 
reported. We observe a very similar behaviour as in the previous phisiological solution. 
Also in this case the amount released in the burst is very similar for the three 
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concentrations, indicating a general behaviour for titanocene complex into 
polycaprolactone. 
 
Fig. 7 
 
Thus, our study indicates that the use of titanocene loaded-PCL devices can alleviate the 
initial burst release and improve the sustainability of nanofiber-based releasing devices. 
 
In vitro antitumor activity of titanocene on Glioblastoma cells 
Glioblastoma is the most common and most aggressive primary brain tumor, with a 
median survival time from diagnosis of up to 1 year. Since the blood brain barrier prevents 
many chemotherapeutic agents from reaching these tumors in adequate concentrations, 
one approach could be targeted drug delivery to a particular site near the tumor to increase 
drug accessibility. Titanocene dichloride previously encapsulated into electrospun fibers 
shows some drawbacks such as low solubility, instability and  short half-life in the human 
body (41), at variance with Titanocene three-chloride is more stable and more active. An 
intracerebral delivery system loading of carmustine [1,3-bis-(2-chloroethyl)-1-nitrosourea] 
has been shown to have promising initial activity and limited toxicity (42). However, 
relatively minor achievements were obtained with this approach, due to the resistance of 
many brain tumors to carmustine, as well as the low stability of the drug and its tendency 
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to ionize at physiological pH. In addition, the major limitations of these implants are in 
attaining the required amount of drug for a given amount of time in a proper distribution 
of the antiproliferative drug.  
To assess the anti-tumor potential of titanocene complex in human glioblastoma cells, A-
172 cells were treated at various concentrations (0, 1, 5, 10, 25, 50, 100, and 150 mg/L) of 
the drug, and cell viability was evaluated by trypan blue dye exclusion assay up 96 h.  
Titanocene complex significantly inhibited the growth of cancer cells in a dose- and time-
dependent manner, showing the half maximal inhibitory concentration (IC50) value of 100 
mg/L at 96 h culture. Surprisingly, the IC50 value of the complex after loading in the 
fibers was 11.60 mg/L after 96 h culture. 
Next, we compared the anti-proliferative effect of the titanocene released from PCL with 
that of equimolar concentrations of titanocene complex, (here with control drug). In detail, 
using Apotox-Glo Triplex Assay we assess viability, cytotoxicity and apoptosis events in 
cells incubated in the presence of control drug (complex 5%) PCL and PCL+complex 5% 
fiber mats. 
Figure 8a, shows that PCL+complex 5% induced a marked decrease in the vitality of A-
172 cells relative to the control (60-65% decrease). Importantly, there was difference 
between the extent of activity of PCL+complex 5% and control drug (p<0.05; Fig. 8), 
indicating that titanocene’s pharmacological activity was increased rather than decreased 
by the incorporation into PCL. Moreover, titanocene complex 5%-loaded PCL exerted 
cytotoxicity on 96 h, as indicated by decreased viability fluorescence and increased 
cytotoxicity fluorescence (Fig. 8b), while, complex 5% control drug, induced 
preferentially cell apoptosis with negligible level of cytotoxicity (Fig. 8c). 
Considering that the concentration of free active complex in the medium was the same in 
all the cultures, these results seem to be apparently in contrast with the current opinion 
that the mechanism of titanocene-induced cell death is concentration dependent. Indeed, to 
maintain the sequence of events which lead to apoptosis, titanocene complex must remain 
under an overly toxic level, otherwise the cells will be driven into necrosis (41). 
To provide answers for these questions we designed a set of experiments in which the 
density of cells were imaged at various time points after being exposed to control PCL or 
PCL+complex 5% (Fig. 8d). 
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A relatively homogenous distribution of cells with approximately the same density was 
observed around the control PCL fiber mat. In contrast, cell density around the 
PCL+complex 5% was significantly reduced at 96 h, whereas their density was higher at a 
relatively far distance from the fiber mat. Thus, we could demonstrate a decrease in cell 
density as a function of increased distance from titanocene-loaded PCL mats. Cell density 
was relatively low near the fiber, (cell exposed to the highest drug concentration), and 
relatively high close to the edge of the well, (cell exposed to a lower drug concentration). 
This correlation is consistent with cell necrosis and apoptosis near and at a greater 
distance from the fiber attributable to high and low drug complex concentrations, 
respectively. 
Accordingly, Fung et al. reported a similar gradient concentration effect using either a 
Carmustine, 4-hydroperoxycyclophosphamide (4-HC), or paclitaxel-loaded polyanhydride 
pellet implanted intracranially in cynomolgus monkeys as a new modality of 
chemotherapy delivery in primates (42). 
Fig. 8 
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Conclusions 
The technical parameters for electrospinning a solution of PCL, and PCL filled with a 
Titanocene complex at different concentrations in acetone, were defined and set up. A 
trial-and-error approach has been employed by varying the solution properties and 
spinning parameters until uniform defect-free fibers are obtained. The morphological 
analysis showed pure PCL fibers with an average diameter of 1.5 µm, whereas the fiber 
dimensions were reduced for PCL filled with the titanocene complex to a mean diameter 
between 0.75 and 1.0 µm, indicating an improved electrospinnability of the mixture 
respect to pure polymer. X-rays indirectly suggested that the complex, encapsulated into 
the PCL fibers, is not allowed to crystallize and exists as amorphous molecular aggregates 
or solid solution into the fibers. The release properties in physiological and phosphate 
buffer solutions show two stages for all the samples: after an initial burst release (first 
stage) released titanocene complex was approximately linearly increased with time, 
extending for very long time (stage II). 
Titanocene complex significantly inhibited the growth of cancer cells in a dose- and time-
dependent manner, showing an IC50 value of 100 mg/L at 96 h culture. Surprisingly, the 
IC50 value of the complex after loading in the fibers indicates that the titanocene  
pharmacological activity was increased rather than decreased by the incorporation into 
PCL. 
Overall, we have described an electrospun PCL delivery platform for a new family of 
compounds that show promising in vitro anti-tumor activity and may provide improved 
treatment options for the management of glioblastoma achieving an adequate drug level 
near the tumor cell. This is of primary importance because an inadequate tumor cell drug-
burden will lead to low cell killing and to a potential for early development of drug 
resistance. 
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Figure legends 
 
Fig. 1 - Fibers diameter distribution of PCL (a), and PCL charged with titanocene at 1% 
(b), 3% (c), and 5% (d). 
Fig. 2 - EDX micrograph of PCL + 5% [C5H4-CH2CH2OCH3] on the surface (a) and after 
thermal degradation of PCL at 450°C(b). 
Fig. 3 - 1H-NMR spectra of: (a) PCL, (b) [C5H4-CH2CH2OCH3]TiCl3 TiCl3 and (c) PCL+ 
5% [C5H4-CH2CH2OCH3]. 
Fig. 4 - X-ray spectra of: (a) [C5H4-CH2CH2OCH3]TiCl3, (b) PCL+ 5% [C5H4-
CH2CH2OCH3]TiCl3 mechanical mixture, electrospun PCL charged with titanocene at 1% 
(c), 3% (d), and 5% (e). 
Fig. 5 -  In vitro release of titanocene complex. 
Fig. 6 - Titanocene mg released vs Titanocene concentration in the membrane. 
Fig. 7.- Percentage of release of titanocene complex in phosphate buffer. 
Fig. 8 - Antitumor activity of titanocene-loaded PCL on A-172 glioblastoma cells at 96 h. 
(a-c) Effect on cell viability, cytotoxicity and apoptosis; (d) effect on cell density around 
control PCL and PCL+complex (5%) fiber mats.* indicated p < 0.05. 
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